Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001512581 | SCV001720026 | benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001512581 | SCV001790681 | likely benign | not provided | 2018-12-21 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV002071879 | SCV002495763 | uncertain significance | Van Maldergem syndrome 2; Hennekam lymphangiectasia-lymphedema syndrome 2 | 2021-03-17 | criteria provided, single submitter | clinical testing | FAT4 NM_024582.4 exon 9 p.Ala3149Thr (c.9445G>A): This variant has not been reported in the literature but is present in 0.03% (5/15258) of Latino alleles, as well as 1 homozygote in South Asian alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/4-125450461-G-A?dataset=gnomad_r3). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ambry Genetics | RCV004980576 | SCV005579842 | likely benign | Inborn genetic diseases | 2024-07-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |